AU2001284418A1 - Novel polypeptide - Google Patents

Novel polypeptide

Info

Publication number
AU2001284418A1
AU2001284418A1 AU2001284418A AU2001284418A AU2001284418A1 AU 2001284418 A1 AU2001284418 A1 AU 2001284418A1 AU 2001284418 A AU2001284418 A AU 2001284418A AU 2001284418 A AU2001284418 A AU 2001284418A AU 2001284418 A1 AU2001284418 A1 AU 2001284418A1
Authority
AU
Australia
Prior art keywords
novel polypeptide
polypeptide
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001284418A
Other versions
AU2001284418B2 (en
Inventor
Hiroyuki Mio
Satoshi Nakagawa
Hisashi Narimatsu
Ayumi Natsume
Katsutoshi Sasaki
Susumu Sekine
Akira Togayachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Co Ltd
Original Assignee
Kyowa Hakko Kirin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd
Priority claimed from PCT/JP2001/007563 external-priority patent/WO2002018602A1/en
Publication of AU2001284418A1 publication Critical patent/AU2001284418A1/en
Assigned to KYOWA HAKKO KOGYO CO., LTD., NARIMATSU, HISASHI reassignment KYOWA HAKKO KOGYO CO., LTD. Request for Assignment Assignors: KYOWA HAKKO KOGYO CO., LTD.
Application granted granted Critical
Publication of AU2001284418B2 publication Critical patent/AU2001284418B2/en
Priority to AU2008200610A priority Critical patent/AU2008200610A1/en
Assigned to NARIMATSU, HISASHI, KYOWA HAKKO KIRIN CO., LTD. reassignment NARIMATSU, HISASHI Alteration of Name(s) in Register under S187 Assignors: KYOWA HAKKO KOGYO CO., LTD., NARIMATSU, HISASHI
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001284418A 2000-09-01 2001-08-31 Novel polypeptide Ceased AU2001284418B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2008200610A AU2008200610A1 (en) 2000-09-01 2008-02-08 Novel polypeptide

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000265430 2000-09-01
JP2000-265430 2000-09-01
PCT/JP2001/007563 WO2002018602A1 (en) 2000-09-01 2001-08-31 Novel polypeptide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2008200610A Division AU2008200610A1 (en) 2000-09-01 2008-02-08 Novel polypeptide

Publications (2)

Publication Number Publication Date
AU2001284418A1 true AU2001284418A1 (en) 2002-06-06
AU2001284418B2 AU2001284418B2 (en) 2007-11-08

Family

ID=18752698

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8441801A Pending AU8441801A (en) 2000-09-01 2001-08-31 Novel polypeptide
AU2001284418A Ceased AU2001284418B2 (en) 2000-09-01 2001-08-31 Novel polypeptide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8441801A Pending AU8441801A (en) 2000-09-01 2001-08-31 Novel polypeptide

Country Status (6)

Country Link
US (2) US7279310B2 (en)
EP (1) EP1316608A4 (en)
JP (1) JP4995398B2 (en)
AU (2) AU8441801A (en)
CA (1) CA2421088A1 (en)
WO (1) WO2002018602A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60216960T2 (en) * 2001-10-26 2007-10-18 Kyowa Hakko Kogyo Co., Ltd. PROCESS FOR PREPARING BETA-1,3-N-ACETYLGLUCOSAMINE TRANSFERASE AND AN N-ACETYLGLUCOSAMINE-CONTAINING SACCHARIDE COMPOSITION
JP2005065687A (en) * 2003-01-23 2005-03-17 National Institute Of Advanced Industrial & Technology beta1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME, AND METHOD FOR TESTING CANCERATION USING THE SAME
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
JP4565177B2 (en) * 2004-07-07 2010-10-20 独立行政法人産業技術総合研究所 Pharmaceutical composition comprising β1,3-N-acetylglucosaminyltransferase for regulating cell migration activity and / or cell differentiation
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Diagnosis of Atherosclerosis
MX2017000621A (en) * 2014-07-14 2017-04-27 Basf Se Biotechnological production of lnt, lnnt and the fucosylated derivatives thereof.
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US20190219593A1 (en) * 2018-01-14 2019-07-18 Elliot Davis Method for identifying neoantigens on cancer cells by using xenoantibodies
US20210040472A1 (en) 2019-08-09 2021-02-11 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition
CN113999810B (en) * 2021-12-30 2022-04-26 北京赛尔富森生物科技有限公司 MRC-5 cell recovery culture solution and recovery method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3170369B2 (en) * 1992-12-16 2001-05-28 協和醗酵工業株式会社 β1,3-galactosyltransferase
AU2284401A (en) * 1999-12-16 2001-06-25 Zymogenetics Inc. Galactosyltransferase homolog, znssp8
WO2002004612A2 (en) 2000-07-07 2002-01-17 Incyte Genomics, Inc. Drug metabolizing enzymes
AU2001288606A1 (en) 2000-08-31 2002-03-13 Millennium Pharmaceuticals, Inc. 8797, a human galactosyltransferase and uses thereof

Similar Documents

Publication Publication Date Title
AU2001284418A1 (en) Novel polypeptide
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU8441801A (en) Novel polypeptide
AU5706000A (en) Useful polypeptide
AU2691500A (en) Novel polypeptide
AU1881200A (en) Novel proteins
AU4778600A (en) Novel polypeptide
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2002218199A1 (en) Truncated phosphodiesterase-7 polypeptides
AU1540701A (en) Novel protein
AU2002224056A1 (en) Novel polypeptide
AU2001278975A1 (en) Alpha-conotoxin peptides
AU2001274750A1 (en) Novel beta-hydroxyamides
AU2109200A (en) Polypeptide
AU2001241044A1 (en) Mitf-associated proteins
AU6637700A (en) Tryptase-like polypeptide ztryp1
AU2001278777A1 (en) Irap-binding protein
AU2001290317A1 (en) Novel peptides
AU2001277614A1 (en) Novel proteins
AU2001234855A1 (en) Neuropeptide-like polypeptide zpep17
AU2001294911A1 (en) Carbohydrate-associated proteins
AUPQ591200A0 (en) Novel peptides
AU2002328853A1 (en) Carcinoma-related peptides
AU2001253019A1 (en) Novel proteins